AMAG Pharmaceuticals Total Liabilities

AMAG Pharmaceuticals (AMAG) currently reports a total liabilities of $480M as of September 2020. That compares with $490M in the prior-year period — down 1.6% year over year. Use the charts on this page to explore AMAG Pharmaceuticals's total liabilities history and peer comparisons.

AMAG Pharmaceuticals's total liabilities decreased from $490M to $480M — a 1.6% year-over-year decrease (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AMAG Pharmaceuticals reported $480M in total liabilities as of September 2020. That compares with $490M in the prior-year period — down 1.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $480M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AMAG Pharmaceuticals, and consider following AMAG for alerts when major investors trade the stock.

AMAG Pharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $480M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMAG with unrelated industries.